Respiratory syncytial virus (RSV) caused significant hospitalizations and severe outcomes in adults, especially those aged 75 ...

Detecting autoantibodies in nasal cavities with swabs could be key to determining how severe COVID ... Ghosn and his lab ...

A genomic test developed by researchers to rapidly detect almost any kind of pathogen -- virus, bacteria, fungus or parasite -- has proved successful after a decade of use.

But a test of a neutralizing antibody’s capabilities showed the neutralizing antibodies prompted by Scharffenberger’s ...

The seasonal COVID-19 spike, combined with rising cases of seasonal flu and RSV, brings what has been called a “tripledemic.” ...

The US Food and Drug Administration granted clearances for various tests for infectious diseases, coagulation disorders, and drug susceptibility.

New research is providing a more precise prediction of COVID-19 severity that can be found by looking at autoantibodies in the nasal cavity, leading to more personalized treatment plans.

COVID-19 presents a broad range of symptoms, varying in intensity from mild to severe and even life-threatening.

A study from Emory University reveals that autoantibodies found in the nasal cavity can help predict and improve COVID-19 recovery. The research indicates that these antibodies regulate inflammation ...

A wide variety of COVID-19 symptoms exist, ranging from mild to severe, and while current strains of the virus generally cause milder symptoms, those with co-morbidities are still at an exponentially ...

A wide variety of COVID-19 symptoms exist, ranging from mild to severe, and while current strains of the virus generally ...